Vitamin K shot debate intensifies: Researcher questions safety data and informed consent for newborns

• Dr. Suzanne Humphries argues media coverage of newborn vitamin K shots relies on fear while downplaying unresolved safety questions and informed consent issues.
• Historical data shows vitamin K deficiency bleeding deaths occurred at 0.26 to 0.9 per 100,000 births before routine shots became standard.
• Some vitamin K shots contain benzyl alcohol, which the FDA recommended be discontinued in neonatal products in 1982.
• Two British studies from the early 1990s suggested a possible link between injectable vitamin K and childhood cancer, though later studies disputed this.
• Naturally low vitamin K levels at birth may serve a biological protective purpose during the critical transition after birth.

The untold story behind newborn vitamin K shots

A growing debate over newborn vitamin K shots is raising questions about whether parents are receiving complete information about risks, benefits and alternatives before giving consent. Dr. Suzanne Humphries, speaking this week on Good Morning CHD, challenged recent headlines warning that babies are “bleeding to death” due to parental refusal of the injection, arguing that media coverage relies heavily on fear while minimizing unresolved safety questions.

The controversy comes as JAMA-published research analyzing more than 5 million births nationwide found that refusals of vitamin K shots nearly doubled between 2017 and 2024, from 2.9% to 5.2%. Doctors report growing alarm, but Humphries contends parents questioning the shot are often dismissed rather than given complete information about the product and available evidence.

Historical risk vs. modern intervention

Before routine vitamin K injections became standard in 1961, deaths from brain bleeds associated with vitamin K deficiency occurred at a rate of approximately 0.26 to 0.9 per 100,000 births, according to older European data cited by Humphries. The rarer, late-onset form of vitamin K deficiency bleeding occurs in an estimated 4 to 7 infants per 100,000.

“Put that into perspective and decide if you want to have this injection put into your baby,” Humphries said. “There is no such thing as zero risk.”

The CDC recommends all newborns receive an intramuscular vitamin K injection shortly after birth. Babies are born with naturally low levels of the nutrient, which helps blood clot normally. However, Humphries challenged the characterization that breast milk is inadequate, noting the implication that “breast milk is just like this innately deficient substance that puts your baby at risk.”

Ingredient concerns and historical warnings

Humphries raised concerns about ingredients in some vitamin K shots, particularly benzyl alcohol, a preservative linked to “gasping syndrome” and infant deaths. In 1982, the FDA recommended benzyl alcohol “should be discontinued” in neonatal products. The CDC website currently lists it as a preservative in some vitamin K products but states the amount used is too small to pose a danger.

The shot also contains aluminum, castor oil, polysorbate 80 and other ingredients. Oral vitamin K alternatives are available but vary in absorption, with some doctors warning that oral drops may not provide adequate protection, particularly for exclusively breastfed infants.

The cancer question that won’t disappear

In 1992, epidemiologist Jean Golding co-published a case-control study in the British Journal of Cancer that found nearly double the odds of childhood cancer among children who received the intramuscular vitamin K shot. The study did not find the same association with oral vitamin K. An earlier 1990 paper had also reported a statistical association between neonatal drug exposure including vitamin K and later childhood cancer.

Later studies dismissed Golding’s findings. But Humphries argued those studies may have been confounded by the dramatic expansion of vaccines given to infants today. “Back in the day that Golding looked at this…there was no vaccine given at birth,” she said. Today, “babies are bombarded” with medical interventions.

The Golding paper itself noted that “a relative deficiency in vitamin K during this critical phase of rapid growth and development may protect vulnerable tissues from mutagenesis.”

Short-term safety studies on the vitamin K shot exist, but long-term studies examining outcomes related to neurodevelopment, fertility and cancer risk have never been conducted, according to FDA labeling information cited by Humphries.

A biological purpose or a defect?

Humphries suggested naturally low vitamin K levels at birth may serve a biological protective purpose rather than represent a defect requiring routine intervention. She connected that theory to the major circulatory changes occurring immediately after birth as a newborn transitions from fetal circulation and takes its first breaths.

“If you’ve got a clot in that system, it could be absolutely devastating for that baby,” Humphries said. Perhaps the low vitamin K level at birth “is by design and that there’s a reason for it and it’s not actually a mistake that humans need to put their hand in, and alter every single newborn.”

The informed consent gap

Dr. Paul Thomas, speaking in related testimony, noted that informed consent faces a bigger problem when doctors lack knowledge about potential links between medical interventions and conditions. If doctors don’t know these risks exist, informed consent is limited to information stating interventions are very safe.

“Without full knowledge, it’s impossible to give fully informed consent,” said Dr. Andrew Wakefield in recorded remarks.

When it comes to specific drugs or vaccines, many physicians rely on package inserts they often don’t read or information from pharmaceutical representatives.

Question of trust and transparency

The vitamin K shot debate represents a broader crisis of medical trust in the United States. Parents are increasingly questioning routine interventions, and doctors report spending more time addressing misconceptions and fears. Respectful conversations can change minds, but the underlying question remains: are families receiving complete information about both risks and benefits before making decisions for their newborns?

“I understand this is a hot topic, and I don’t want to disrespect anybody,” said Dr. Tom Patterson, an Idaho pediatrician. “But at the same time, I’m desperately saddened that we’re losing babies for no reason.” As research continues and public scrutiny intensifies, the demand for transparency and patient-centered informed consent shows no signs of diminishing.

Sources for this article include:

ChildrensHealthDefense.org

APNews.com

CDC.gov